Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adenylosuccinate synthase pseudogene is a segment of DNA located in the human genome that closely resembles the functional adenylosuccinate synthase gene but contains disabling mutations (such as frameshifts or premature stop codons) that render it incapable of producing a functional enzyme. Pseudogenes are a common genomic feature, formed through gene duplication or retrotransposition events, and persist as non-functional relics, often referred to as "junk DNA." They have no known biological activity and are not involved in cellular metabolic pathways, drug interactions, or disease mechanisms. The functional gene (adenylosuccinate synthase, encoded by ADSS or ADSS2) plays a critical role in purine nucleotide biosynthesis, but the pseudogene is not expressed as an active protein and thus is not a target for therapeutic intervention or drug development.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenylosuccinate synthase pseudogene (null).